Versoza, Danilo, III. F.

HRN: 28-77-10  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/04/2026
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
04/04/2026
04/11/2026
ORAL
2ml
QID
Oral Thrush
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Eye, Ear, Nose, Throat, & Mouth    Compliance to guidelines: